Guggenheim Capital’s Nektar Therapeutics NKTR Stock Holding History

Guggenheim Capital’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,031	Closed	-$2M	–	2093
2020 Q3	$2M	Sell	8,031 -1,986	-20%	-$494K	0.01%	895
2020 Q2	$3.48M	Buy	10,017 +1,449	+17%	+$503K	0.03%	658
2020 Q1	$2.29M	Sell	8,568 -1,965	-19%	-$526K	0.02%	722
2019 Q4	$3.41M	Sell	10,533 -1,595	-13%	-$516K	0.03%	802
2019 Q3	$3.31M	Buy	12,128 +2,619	+28%	+$716K	0.03%	798
2019 Q2	$5.08M	Sell	9,509 -699	-7%	-$373K	0.04%	591
2019 Q1	$5.15M	Buy	10,208 +590	+6%	+$297K	0.04%	596
2018 Q4	$4.74M	Buy	9,618 +466	+5%	+$230K	0.04%	601
2018 Q3	$8.37M	Buy	9,152 +169	+2%	+$155K	0.05%	435
2018 Q2	$6.58M	Sell	8,983 -32,974	-79%	-$24.1M	0.04%	536
2018 Q1	$66.9M	Buy	41,957 +31,887	+317%	+$50.8M	0.16%	156
2017 Q4	$9.02M	Sell	10,070 -3,099	-24%	-$2.78M	0.02%	726
2017 Q3	$4.74M	Sell	13,169 -2,620	-17%	-$943K	0.01%	1094
2017 Q2	$4.63M	Sell	15,789 -285	-2%	-$83.6K	0.01%	1064
2017 Q1	$5.66M	Sell	16,074 -1,596	-9%	-$562K	0.02%	946
2016 Q4	$3.25M	Sell	17,670 -2,971	-14%	-$547K	0.01%	1290
2016 Q3	$5.32M	Sell	20,641 -3,003	-13%	-$774K	0.02%	982
2016 Q2	$5.05M	Sell	23,644 -1,610	-6%	-$344K	0.02%	994
2016 Q1	$5.21M	Sell	25,254 -21,589	-46%	-$4.45M	0.02%	969
2015 Q4	$11.8M	Sell	46,843 -7,767	-14%	-$1.96M	0.03%	689
2015 Q3	$8.98M	Buy	54,610 +4,395	+9%	+$722K	0.03%	798
2015 Q2	$9.42M	Buy	50,215 +22,335	+80%	+$4.19M	0.02%	860
2015 Q1	$4.6M	Buy	27,880 +7,597	+37%	+$1.25M	0.01%	1197
2014 Q4	$4.72M	Buy	20,283 +2,324	+13%	+$540K	0.01%	1152
2014 Q3	$3.25M	Sell	17,959 -334	-2%	-$60.5K	0.01%	1409
2014 Q2	$3.52M	Sell	18,293 -3,395	-16%	-$653K	0.01%	1375
2014 Q1	$3.94M	Buy	21,688 +1,129	+5%	+$205K	0.01%	1266
2013 Q4	$3.5M	Buy	20,559 +969	+5%	+$165K	0.01%	1282
2013 Q3	$3.07M	Buy	19,590 +2,481	+15%	+$389K	0.01%	1322
2013 Q2	$2.96M	Buy	+17,109	New	+$2.96M	0.01%	1294